Related Experiment Videos
Immunological detection of DNA damage caused by melphalan using monoclonal antibodies
Abstract:
Immunological detection of melphalan adducts on DNA should permit new types of clinical and experimental investigations. Five cloned rat hybridoma cell lines were derived, each producing an antibody that bound to DNA alkylated with melphalan (phenylalanine mustard) but not to normal DNA. Further characterization of one melphalan specific antibody (MP5/73) used a competitive fluorogenic enzyme-linked immunoabsorbent assay. Using denatured DNA, 50% inhibition of antibody binding was caused by 30 fmol of total melphalan adducts (determined using radioactive melphalan) per assay well. Denatured control DNA caused 16 to 24% inhibition at 45 micrograms (130 nmol)/well, the maximum concentration tested. Adducts on RNA behaved similarly to those on denatured DNA. Adducts on native DNA caused 50% inhibition at 272 to 1335 fmol/well dependent upon alkylation frequency and sonication treatment. Native control DNA caused no detectable inhibition at 45 micrograms/well. The adducts recognized by the antibody were thermo- and alkali labile. Denaturation of the alkylated DNA by moderate heating in the presence of 75% formamide gave 50% inhibition at 50 fmol/well, indicating that only 5% of the recognized adducts could bind antibody in native DNA.
Insights
Researchers developed a new method for detecting melphalan DNA adducts using specific antibodies. This immunological detection allows for novel clinical and experimental studies of melphalan
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Melphalan (phenylalanine mustard) is a chemotherapeutic agent that forms adducts on DNA.
- Accurate detection of these adducts is crucial for understanding drug efficacy and toxicity.
- Existing detection methods may have limitations in sensitivity or specificity.
Purpose of the Study:
- To develop and characterize a novel immunological method for detecting melphalan adducts on DNA.
- To assess the sensitivity and specificity of a melphalan-specific antibody.
- To investigate the stability and accessibility of melphalan adducts on DNA and RNA.
Main Methods:
- Generation of hybridoma cell lines producing antibodies against melphalan-DNA adducts.
- Characterization of a specific antibody (MP5/73) using a competitive fluorogenic enzyme-linked immunosorbent assay (ELISA).
- Quantification of melphalan adducts using radioactive melphalan and assessment of antibody binding to native and denatured DNA/RNA.
Main Results:
- Five hybridoma cell lines produced antibodies specific to melphalan-alkylated DNA.
- The MP5/73 antibody demonstrated high sensitivity, with 50% inhibition at 30 fmol of adducts on denatured DNA.
- Adducts on RNA showed similar binding characteristics to denatured DNA; adducts on native DNA required higher concentrations for detection.
- The recognized adducts were found to be thermo- and alkali labile.
Conclusions:
- A sensitive and specific immunological assay for detecting melphalan DNA adducts has been established.
- This method enables new avenues for clinical and experimental investigations into melphalan's effects.
- The antibody's performance suggests its utility in various biological and medical research settings.